Abstract
The cytokine growth factor, G-CSF (granulocyte colony-stimulating factor), is commonly used in oncologic practice and is generally believed to be a safe agent to administer. We describe here a case of pulmonary toxicity associated with the concurrent administration of G-CSF and doxorubicin. We contend that G-CSF contributed to the life-threatening lung injury in our patient, and discuss additional reports in the literature of pulmonary toxicity associated with the use of this agent.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Additional information
Received: 3 January 2000 / Accepted: 6 July 2000
Rights and permissions
About this article
Cite this article
Eisenbeis, C., Winn, D., Poelman, S. et al. A case of pulmonary toxicity associated with G-CSF and doxorubicin administration. Ann Hematol 80, 121–123 (2001). https://doi.org/10.1007/s002770000232
Issue Date:
DOI: https://doi.org/10.1007/s002770000232